Back
Nuveen New York Municipal Value Fund Vs. Aligos Therapeutics Industry Stock Comparison
Sell
48
NNY
Nuveen New York Municipal Value Fund
Last Price:
$8.15
Seasonality Move:
1.2%
Buy
69
ALGS
Aligos Therapeutics
Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
48
Nuveen New York Municipal Value Fund (NNY)
is a Sell
Is Nuveen New York Municipal Value Fund a Buy, Sell or Hold?
-
The current Nuveen New York Municipal Value Fund [NNY] share price is $8.17. The Score for NNY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
NNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NNY Stock Price Chart
What is Nuveen New York Municipal Value Fund's stock price today?
-
The Nuveen New York Municipal Value Fund share price today is $8.17The current trend is relatively stagnant and NNY is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 49.09 | Sell |
| Chaikin Money Flow: | 11774 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.05 - 8.37) | Sell |
| Bollinger Bands (100): | (8.25 - 8.57) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.14 | Buy |
| Relative Strength Index (14 RSI): | 74.33 | Buy |
| Chaikin Money Flow: | 210748 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.82 - 40.1) | Buy |
| Bollinger Bands (100): | (6.77 - 28.07) | Buy |
NNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.04 | Buy |
| 20-day SMA: | 8.16 | Buy |
| 50-day SMA: | 8.29 | Sell |
| 200-day SMA: | 8.34 | Sell |
| 8-day EMA: | 8.08 | Buy |
| 20-day EMA: | 8.14 | Buy |
| 50-day EMA: | 8.26 | Sell |
| 200-day EMA: | 8.34 | Sell |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.78 | Buy |
| 20-day SMA: | 36.11 | Buy |
| 50-day SMA: | 23.97 | Buy |
| 200-day SMA: | 16.97 | Buy |
| 8-day EMA: | 40.32 | Buy |
| 20-day EMA: | 35.95 | Buy |
| 50-day EMA: | 27.43 | Buy |
| 200-day EMA: | 19.22 | Buy |
Nuveen New York Municipal Value Fund Earnings Growth & NNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Nuveen New York Municipal Value Fund Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||